Yidao Bio Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $25.2M

  • Investors
  • 9

Yidao Bio General Information

Description

Developer of vaccines and biopharmaceutical products designed to prevent infectious diseases and improve human health outcomes. The company offers recombinant protein antigen vaccines, viral vector vaccines, messenger RNA vaccines, conjugate vaccines, and proprietary adjuvant technologies, enabling healthcare providers and immunisation programs to access advanced preventive therapies and broaden disease protection.

Contact Information

Formerly Known As
Shanghai Adnex Biotechnology, Shanghai Yidao Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 407 Jianlin Road
  • Suzhou High-tech Zone
  • Suzhou, Jiangsu 215100
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Number 407 Jianlin Road
  • Suzhou High-tech Zone
  • Suzhou, Jiangsu 215100
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Yidao Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 09-May-2024 $25.2M Completed Generating Revenue
5. Later Stage VC (Series C) 04-May-2021 Completed Generating Revenue
4. Secondary Transaction - Private 20-Apr-2021 Completed Generating Revenue
3. Early Stage VC (Series B) 01-May-2020 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Aug-2018 Completed Generating Revenue
1. Corporate 08-Jun-2018 Completed Generating Revenue
To view Yidao Bio’s complete valuation and funding history, request access »

Yidao Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Yidao Bio Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cathay Capital PE/Buyout Minority
Loyal Valley Capital Growth/Expansion Minority
OrbiMed Growth/Expansion Minority
Qiming Venture Partners Venture Capital Minority
Green Pine Capital Partners Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Yidao Bio FAQs

  • When was Yidao Bio founded?

    Yidao Bio was founded in 2017.

  • Where is Yidao Bio headquartered?

    Yidao Bio is headquartered in Suzhou, China.

  • What is the size of Yidao Bio?

    Yidao Bio has 6 total employees.

  • What industry is Yidao Bio in?

    Yidao Bio’s primary industry is Drug Discovery.

  • Is Yidao Bio a private or public company?

    Yidao Bio is a Private company.

  • What is Yidao Bio’s current revenue?

    The current revenue for Yidao Bio is .

  • How much funding has Yidao Bio raised over time?

    Yidao Bio has raised $86.6M.

  • Who are Yidao Bio’s investors?

    Cathay Capital, Loyal Valley Capital, OrbiMed, Qiming Venture Partners, and Green Pine Capital Partners are 5 of 9 investors who have invested in Yidao Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process